INS and hyperandrogenism: Enhancement of insulin sensitivity, aiding in glucose regulation and reducing the risk of type 2 diabetes. Reduction in hyperinsulinemia, mitigating insulin-driven androgen production and addressing symptoms associated with androgen excess. Management of metabolic complications, such as hyperinsulinemia and dyslipidemia.